Original Study| Volume 23, ISSUE 2, P176-180, February 2023

Download started.


Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery

Published:November 30, 2022DOI:



      To evaluate the dosimetric data, early toxicity, and patient-reported cosmetic outcomes in breast cancer patients treated with adjuvant proton-based radiotherapy (RT) after breast-conserving surgery.

      Materials and Methods

      We performed a retrospective review of our institutional database to identify breast cancer patients treated with breast-conserving surgery followed by proton-based RT from 2015 to 2020. Patient-reported cosmetic outcomes were graded as excellent, good, fair, or poor. Early toxicity outcomes were graded by the treating physician during treatment. Dose-volume histograms were reviewed to obtain dosimetry data.


      We identified 21 patients treated with adjuvant proton-based RT. Median whole breast dose delivered was 46.8 Gy (range, 40.0-50.4 Gy). Target volumes included the regional lymph nodes in 17 patients (81%). Seventeen patients (81%) received a lumpectomy boost. The median planning target volume V95 was 94% (range, 77%-100%), V100 71% (range, 60%-97%), V110 2% (range 0%-18%), and median max point dose was 115% (range, 105%-120%). The median ipsilateral breast V105 was 367.3 cc (range, 0-1172 cc) and V110 was 24.1 cc (range, 0-321.3 cc). Grade 2 and 3 dermatitis occurred in 62% and 14% of patients, respectively. Grade 2 and 3 pain was reported by 33% and 10% of patients, respectively. Median follow-up at the time of cosmetic evaluation was 27 months (range, 5-42 months). Four patients (21%) reported fair cosmetic outcome and 15 patients (79%) reported good or excellent cosmetic outcome. No poor cosmesis was reported.


      Adjuvant proton-based radiotherapy after breast-conserving surgery is well tolerated with acceptable rates of acute toxicities and a high rate of good-to-excellent patient-reported cosmetic outcomes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pearlstein KA
        • Chen RC.
        Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer.
        Semin Radiat Oncol. 2013; 23: 182-190
        • Cardoso MJ
        • Cardoso J
        • Santos AC
        • et al.
        Factors determining esthetic outcome after breast cancer conservative treatment.
        Breast J. 2007; 13: 140-146
        • Cochrane RA
        • Valasiadou P
        • Wilson AR
        • Al-Ghazal SK
        • Macmillan RD.
        Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised.
        Br J Surg. 2003; 90: 1505-1509
        • Vrieling C
        • Collette L
        • Fourquet A
        • et al.
        The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC radiotherapy and breast cancer cooperative groups.
        Radiother Oncol. 2000; 55: 219-232
        • Ciammella P
        • Podgornii A
        • Galeandro M
        • et al.
        Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
        Radiat Oncol. 2014; 9: 97
        • Taylor ME
        • Perez CA
        • Halverson KJ
        • et al.
        Factors influencing cosmetic results after conservation therapy for breast cancer.
        Int J Radiat Oncol Biol Phys. 1995; 31: 753-764
        • Rose MA
        • Olivotto I
        • Cady B
        • et al.
        Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results.
        Arch Surg. 1989; 124: 153-157
        • Hau E
        • Browne LH
        • Khanna S
        • et al.
        Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial.
        Int J Radiat Oncol Biol Phys. 2012; 82: 682-689
        • Vicini F
        • Jones P
        • Rivers A
        • et al.
        Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy.
        Cancer. 2010; 116: 3485-3492
        • Hill-Kayser CE
        • Chacko D
        • Hwang WT
        • Vapiwala N
        • Solin LJ.
        Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost.
        Int J Radiat Oncol Biol Phys. 2011; 79: 1048-1054
        • Sayan M
        • Hard D
        • Wilson K
        • et al.
        Long-term cosmesis following a novel schedule of accelerated partial breast radiation in selected early stage breast cancer: result of a prospective clinical trial.
        Radiat Oncol J. 2017; 35: 325-331
        • Margolis GJ
        • Goodman RL.
        Psychological factors in women choosing radiation therapy for breast cancer.
        Psychosomatics. 1984; 25 (9): 464-466
        • Sacchini V
        • Luini A
        • Tana S
        • et al.
        Quantitative and qualitative cosmetic evaluation after conservative treatment for breast cancer.
        Eur J Cancer. 1991; 27: 1395-1400
        • Al-Ghazal SK
        • Blamey RW.
        Cosmetic assessment of breast-conserving surgery for primary breast cancer.
        Breast. 1999; 8: 162-168
        • Johansen J
        • Overgaard J
        • Rose C
        • et al.
        Cosmetic outcome and breast morbidity in breast-conserving treatment–results from the Danish DBCG-82TM national randomized trial in breast cancer.
        Acta Oncol. 2002; 41: 369-380
        • Hamilton CS
        • Nield JM
        • Adler GF
        • Clingan PR.
        Breast appearance and function after breast conserving surgery and radiotherapy.
        Acta Oncol. 1990; 29: 291-295
        • Amichetti M
        • Busana L
        • Caffo O.
        Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer.
        Oncology. 1995; 52: 177-181
        • Sneeuw KC
        • Aaronson NK
        • Yarnold JR
        • et al.
        Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments.
        Radiother Oncol. 1992; 25: 153-159
        • Romestaing P
        • Lehingue Y
        • Carrie C
        • et al.
        Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.
        J Clin Oncol. 1997; 15: 963-968
        • Galland-Girodet S
        • Pashtan I
        • MacDonald SM
        • et al.
        Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial.
        Int J Radiat Oncol Biol Phys. 2014; 90: 493-500
        • Bush DA
        • Do S
        • Lum S
        • et al.
        Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes.
        Int J Radiat Oncol Biol Phys. 2014; 90: 501-505
        • Teichman SL
        • Do S
        • Lum S
        • et al.
        Improved long-term patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast proton therapy.
        Cancer Med. 2018; 7: 6064-6076
        • Kim JY
        • Jung SY
        • Lee S
        • et al.
        Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
        Int J Radiat Oncol Biol Phys. 2013; 87: 1037-1042
        • Jimenez RB
        • Hickey S
        • DePauw N
        • et al.
        Phase II study of proton beam radiation therapy for patients with breast cancer requiring regional nodal irradiation.
        J Clin Oncol. 2019; 37: 2778-2785
        • Bradley JA
        • Dagan R
        • Ho MW
        • et al.
        Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons.
        Int J Radiat Oncol Biol Phys. 2016; 95: 411-421
        • Verma V
        • Iftekaruddin Z
        • Badar N
        • et al.
        Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer.
        Radiother Oncol. 2017; 123: 294-298
        • Sayan M
        • Wilson K
        • Nelson C
        • Gagne H
        • Rubin D
        • Heimann R.
        A novel schedule of accelerated partial breast radiation using intensity-modulated radiation therapy in elderly patients: survival and toxicity analysis of a prospective clinical trial.
        Radiat Oncol J. 2017; 35: 32-38